IP vs XBIO · P/E 43, $26.62B cap vs rev $2.5M
International Paper (IP) versus Xenetic Biosciences Inc (XBIO) — a side-by-side from cached financials, not a winner call.
International Paper (IP) is a packaging & containers company listed on US.
Xenetic Biosciences Inc (XBIO) is a biotechnology company listed on US.
IP does not have a complete income-statement cache yet.
Latest reported XBIO revenue for 2024-12-31 was $2.5M. Net income was -$4.0M. Revenue was down 1.6% from 2023-12-31 to 2024-12-31. XBIO currently screens at market cap $5.7M.
IP currently screens at market cap $26.62B and trailing P/E 43.1. XBIO currently screens at market cap $5.7M.
Not investment advice. Open the IP and XBIO stock pages for the full models.
Not investment advice.